« Back
Home /
Silodosin

Silodosin

Manufacturer	MedChem Express
Category	Oncology Metabolism Diabetes Glucose Homeostasis Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer Uterine, Ovarian & Cervical Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	50 mg
Item no.	HY-10122-50mg
Targets	Adrenergic Receptor
CASRN	160970-54-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Silodosin (KAD 3213; KMD 3213) is a potent, selective and orally active α1A-adrenergic receptor (α1A-AR) blocker. Silodosin exhibits high affinity for α1A-AR (Ki=0.036 nM), over 162-fold and 50-fold than for α1B-AR and α1D-AR with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent, it can be used for the investigation of LUTS/BPH[1][3].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
MolecularWeight	495.53
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Endocrinology
Solubility	DMSO : ≥ 50 mg/mL
Manufacturers Target	Adrenergic Receptor; Bacterial
Pathway	Anti-infection; GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10122-50mg-safety-datasheet.pdf